[
  {
    "start": "0",
    "end": "74000"
  },
  {
    "text": "good afternoon everyone and thank you all for joining us today for our webinar in partnership with the Kraft precision",
    "start": "1690",
    "end": "9080"
  },
  {
    "text": "medicine accelerator at the Harvard Business School exploring the frontiers of data and analytics for precision",
    "start": "9080",
    "end": "15800"
  },
  {
    "text": "medicine this is Emily ball speaking from faster cures we're looking forward to an engaging presentation and",
    "start": "15800",
    "end": "22189"
  },
  {
    "text": "discussion this afternoon before we begin I just wanted to mention some brief housekeeping items",
    "start": "22189",
    "end": "28909"
  },
  {
    "text": "so all participants are muted on entry but you do have the ability to communicate with us here at faster cures",
    "start": "28909",
    "end": "35660"
  },
  {
    "text": "by using the chat feature at the bottom right hand corner of your screen we will",
    "start": "35660",
    "end": "41240"
  },
  {
    "text": "have a time for Q&A at the end of the presentation and we welcome your questions so feel free to send us those",
    "start": "41240",
    "end": "46940"
  },
  {
    "text": "by using that same chat feature we also welcome you to join us on Twitter to follow along with the conversation and",
    "start": "46940",
    "end": "54170"
  },
  {
    "text": "share your own voice with the discussion you can follow along or tweet about the event using the hashtag SP webinar we",
    "start": "54170",
    "end": "61820"
  },
  {
    "text": "will be tweeting from our handle at faster cures and with that I will turn it over to our moderator this afternoon",
    "start": "61820",
    "end": "67539"
  },
  {
    "text": "faster cures executive director Tanisha Korea thanks Emily hi everyone thanks",
    "start": "67539",
    "end": "73909"
  },
  {
    "text": "again for being with us my name is Tanisha Kirino and like Emily said I'm the executive director of faster cures",
    "start": "73909",
    "end": "79939"
  },
  {
    "start": "74000",
    "end": "74000"
  },
  {
    "text": "I'm extremely excited that our team has the opportunity to partner with the crop precision medicine accelerator at the",
    "start": "79939",
    "end": "86569"
  },
  {
    "text": "Harvard Business School and to bring you this webinar webinar about the frontiers of precision medicine by way of setting",
    "start": "86569",
    "end": "93799"
  },
  {
    "text": "the stage I'd like to take a minute to share some background about faster cures introduce our two speakers and talk a",
    "start": "93799",
    "end": "99409"
  },
  {
    "text": "bit about why their work is so significant to our team into our field to share some context for those of you",
    "start": "99409",
    "end": "106609"
  },
  {
    "text": "on the call this afternoon who may be new to our work faster cures is driven by a singular goal to save lives by",
    "start": "106609",
    "end": "113299"
  },
  {
    "text": "speeding science to all patients we host these free webinars to convene around",
    "start": "113299",
    "end": "118609"
  },
  {
    "start": "116000",
    "end": "116000"
  },
  {
    "text": "important topics that matter to patients and stakeholders across the field and to learn more from experts with real-world",
    "start": "118609",
    "end": "124520"
  },
  {
    "text": "experience in dealing with these topics our hope is that the webinars provide opportunities to bring actionable",
    "start": "124520",
    "end": "131180"
  },
  {
    "text": "knowledge to our network that can spur on medical progress by bringing to light solutions",
    "start": "131180",
    "end": "136220"
  },
  {
    "text": "to the fields biggest challenges on the call this afternoon will have over 400",
    "start": "136220",
    "end": "141560"
  },
  {
    "text": "registrants from a diverse background and it's wonderful to have so many voices on the call all seeking tips for",
    "start": "141560",
    "end": "148880"
  },
  {
    "text": "how data and analytics are pushing forward the field of precision medicine but before I move on to introduce our",
    "start": "148880",
    "end": "155540"
  },
  {
    "text": "speakers I wanted to thread the needle on this topic and highlight why it's so critical for us if a structures one area",
    "start": "155540",
    "end": "162320"
  },
  {
    "text": "that I know you all has been focused on as well as often last year is the role of health data this is a particularly",
    "start": "162320",
    "end": "168440"
  },
  {
    "text": "challenging bill where there are so many sources of health data and that the data have tremendous value for improving",
    "start": "168440",
    "end": "175160"
  },
  {
    "text": "biomedical Ardi and finding cures for individual patients who need them however there are often disconnected",
    "start": "175160",
    "end": "181730"
  },
  {
    "text": "from the use of this data across the healthcare system and the majority of patients and caregivers still don't have",
    "start": "181730",
    "end": "187970"
  },
  {
    "text": "resources to utilize their data in meaningful ways to address these challenges that we've created it faster",
    "start": "187970",
    "end": "194930"
  },
  {
    "text": "cures a project called health data basics which you can visit and learn more about at health databases org",
    "start": "194930",
    "end": "200570"
  },
  {
    "text": "what we've discovered is that patient participation is so critical and if we're going to bridge the gap between",
    "start": "200570",
    "end": "206450"
  },
  {
    "text": "science and the results for patients themselves we have to build a committed community of people who are dedicated to",
    "start": "206450",
    "end": "212540"
  },
  {
    "text": "advancing patient engagement with their own data so we're excited to see how this work with craft and the work that",
    "start": "212540",
    "end": "219500"
  },
  {
    "text": "you're doing in precision medicine will bring individualized results to specific patient communities and in the context",
    "start": "219500",
    "end": "226100"
  },
  {
    "text": "of our own focus for the future I'm excited to introduce you the craft team who will share more about their work",
    "start": "226100",
    "end": "231800"
  },
  {
    "text": "this afternoon so we have the pleasure this afternoon from here of hearing from",
    "start": "231800",
    "end": "238550"
  },
  {
    "text": "Kathy Ducey and Gabriel Asher who are both with us today Kathy's been a good",
    "start": "238550",
    "end": "244790"
  },
  {
    "text": "friend of faster cures for over a decade the multiple myeloma Research Foundation which Kathy founded is a pioneer in the",
    "start": "244790",
    "end": "251840"
  },
  {
    "text": "field of venture philanthropy and in sharing experiences and resources of countless of other patient organizations",
    "start": "251840",
    "end": "258590"
  },
  {
    "text": "for a number of years Kathy has been focused on the importance of high quality data and",
    "start": "258590",
    "end": "263780"
  },
  {
    "text": "analytics in pursuit of precision medicine now at the Kraft precision medicine accelerator she has a new perch",
    "start": "263780",
    "end": "270260"
  },
  {
    "text": "from which to advance thinking and practice on this topic along with many other topics we were also delighted to",
    "start": "270260",
    "end": "277010"
  },
  {
    "text": "have Gabriel present with us this afternoon he has spent the last 15 years working to apply healthcare technologies",
    "start": "277010",
    "end": "283160"
  },
  {
    "text": "to problems in the pharma biotech industry in the delivery of healthcare Gabriel was formerly the VP of products",
    "start": "283160",
    "end": "290240"
  },
  {
    "text": "at gnf healthcare prior to that he managed several global client programs that PatientsLikeMe",
    "start": "290240",
    "end": "295820"
  },
  {
    "text": "focused on patient centered research and real-world outcomes this afternoon Gabriel will share the results of a very",
    "start": "295820",
    "end": "302180"
  },
  {
    "text": "interesting and relevant landscape the craft is done on the sources of data for precision medicine R&D and those who",
    "start": "302180",
    "end": "308660"
  },
  {
    "text": "provide analytical capabilities across the ecosystem so with that I'll turn it",
    "start": "308660",
    "end": "313970"
  },
  {
    "text": "over to Kathy thank you so much Tanisha and thank you fat recursion to all of",
    "start": "313970",
    "end": "321590"
  },
  {
    "text": "you for joining us today we're so excited to give you an update on the HBS craft precision medicine accelerator and",
    "start": "321590",
    "end": "328220"
  },
  {
    "text": "I speak today on behalf of my co-chair Richard hammer mesh and myself so to",
    "start": "328220",
    "end": "333590"
  },
  {
    "text": "give you an understanding of how the Kraft precision medicine accelerator got",
    "start": "333590",
    "end": "338690"
  },
  {
    "text": "started we want to thank Robert and Jonathan Kraft who about two and a half",
    "start": "338690",
    "end": "344540"
  },
  {
    "text": "years ago decided that they wanted to give a 20 million dollar endowment to Harvard Business School and that",
    "start": "344540",
    "end": "350930"
  },
  {
    "text": "generous endowment came from the heart because Robert had lost his wife Myra to ovarian cancer they sequenced her genome",
    "start": "350930",
    "end": "358310"
  },
  {
    "text": "and couldn't find a drugs fast enough for her and the crafts were wise enough to understand right away that while",
    "start": "358310",
    "end": "364460"
  },
  {
    "text": "science and technology are exploding in the field the business incentives aren't",
    "start": "364460",
    "end": "369979"
  },
  {
    "text": "always keeping up so when the endowment came to the business school we were really excited because we could use the",
    "start": "369979",
    "end": "375950"
  },
  {
    "text": "faculty the students the alumni but really focus on how the new incentives drive great models in precision medicine",
    "start": "375950",
    "end": "382540"
  },
  {
    "text": "for Richard and myself we really wanted to make sure that craft focused on solving problems and doing it in the",
    "start": "382540",
    "end": "389210"
  },
  {
    "text": "long haul so we start by always creating landscapes in the precision medicine space we then identify the leaders the",
    "start": "389210",
    "end": "396880"
  },
  {
    "text": "directors the best practices and agree on what we think the greatest problems",
    "start": "396880",
    "end": "401920"
  },
  {
    "text": "and challenges are we keep our teams close at hand working with us on a long haul to devise really good solutions and",
    "start": "401920",
    "end": "410200"
  },
  {
    "text": "then we disseminate those solutions through groups like faster cures to make sure that we continue to build the",
    "start": "410200",
    "end": "416590"
  },
  {
    "text": "landscape in a really strong way now when Richard and I started we did a",
    "start": "416590",
    "end": "421840"
  },
  {
    "start": "418000",
    "end": "418000"
  },
  {
    "text": "number of phone calls of all of the leaders in precision medicine to really understand where should we focus all of",
    "start": "421840",
    "end": "429190"
  },
  {
    "text": "our time it really broke down into four different areas and they're not surprising but they are highly highly",
    "start": "429190",
    "end": "435820"
  },
  {
    "text": "integrated the first is direct to patient and why this was critical is if",
    "start": "435820",
    "end": "441190"
  },
  {
    "text": "the patient's don't understand the importance of their own data in their own journey and in a collective way with",
    "start": "441190",
    "end": "447970"
  },
  {
    "text": "other data we will never make precision medicine happen the second was once the patients are",
    "start": "447970",
    "end": "454540"
  },
  {
    "text": "able to give their data through pharmaceutical clinical trials or academic centers or foundation",
    "start": "454540",
    "end": "460090"
  },
  {
    "text": "registries we have to frame the questions in the right way so that we can get use cases and analytics to drive",
    "start": "460090",
    "end": "467230"
  },
  {
    "text": "and aggregate data sets together that in itself helps us to identify new targets",
    "start": "467230",
    "end": "472750"
  },
  {
    "text": "and new biomarkers that we need to get into much more efficient clinical trials",
    "start": "472750",
    "end": "478750"
  },
  {
    "text": "and we ended up focusing specifically on platform trials which then helped us to",
    "start": "478750",
    "end": "484630"
  },
  {
    "text": "understand where should venture really be investing these days to drive towards",
    "start": "484630",
    "end": "490120"
  },
  {
    "text": "forward so that we can help all of the patients who have their own journey specifically in oncology and in",
    "start": "490120",
    "end": "497170"
  },
  {
    "text": "precision medicine now what's the easiest for us to do to help you to",
    "start": "497170",
    "end": "502270"
  },
  {
    "text": "understand how the craft accelerator works is to walk you through each of the four work streams but we can promise you",
    "start": "502270",
    "end": "508660"
  },
  {
    "text": "that the team up here at Harvard consistently needs to make sure that we're always integrating these four work",
    "start": "508660",
    "end": "515409"
  },
  {
    "text": "streams to drive toward cures faster but starting with direct to patient the the",
    "start": "515410",
    "end": "522310"
  },
  {
    "text": "real challenge we saw there was that cancer patients of course are overwhelmed and we had done a survey and",
    "start": "522310",
    "end": "528520"
  },
  {
    "text": "really understood that about 54% didn't know what precision medicine was 84 80% weren't really",
    "start": "528520",
    "end": "536180"
  },
  {
    "text": "familiar with the genomic testing so thanks to Lori Markus who chairs this",
    "start": "536180",
    "end": "541730"
  },
  {
    "text": "direct to patient work stream we decided to reach out to five different cancer",
    "start": "541730",
    "end": "548750"
  },
  {
    "text": "organizations who have been terrific to work with pan cam Breast Cancer Research",
    "start": "548750",
    "end": "553820"
  },
  {
    "text": "Foundation MMRF PCF longevity and together which i found itself",
    "start": "553820",
    "end": "558830"
  },
  {
    "text": "fascinating together these five groups chief marketing officers digital people they don't call every week to identify",
    "start": "558830",
    "end": "567020"
  },
  {
    "text": "how can they really build patient engagement and retention in a precision",
    "start": "567020",
    "end": "573050"
  },
  {
    "text": "medicine journey and what we did that was so innovative and exciting was we",
    "start": "573050",
    "end": "578780"
  },
  {
    "text": "worked with so many people in the direct-to-consumer space from Marriott liebe Palatine you name it and they came",
    "start": "578780",
    "end": "586040"
  },
  {
    "text": "in and really helped us to understand the engagement and retention that they",
    "start": "586040",
    "end": "591440"
  },
  {
    "text": "all use in the retail space and the service industry so that we can understand how to apply it in healthcare",
    "start": "591440",
    "end": "598220"
  },
  {
    "text": "as a result of all this work the five cancers then developed a program called right track which is simple but it",
    "start": "598220",
    "end": "605600"
  },
  {
    "text": "really is meaningful it's just saying patients have to get to the right team an academic center understand right",
    "start": "605600",
    "end": "611120"
  },
  {
    "text": "tests genomic or even immuno profiling and to the right treatment standard of",
    "start": "611120",
    "end": "616430"
  },
  {
    "text": "care or a clinical trial and now all of the organizations are working with a",
    "start": "616430",
    "end": "622400"
  },
  {
    "text": "social media campaign and doing this in a really thoughtful and efficient way together and we're analyzing the impact",
    "start": "622400",
    "end": "629900"
  },
  {
    "text": "of the social media campaign around right track to say where are we able to",
    "start": "629900",
    "end": "635120"
  },
  {
    "text": "close some of the knowledge gaps that we saw in precision medicine our patients much more knowledgeable about what",
    "start": "635120",
    "end": "641960"
  },
  {
    "text": "precision medicine is the subtypes the testing that they need to have we'll be looking at all the information we get",
    "start": "641960",
    "end": "648560"
  },
  {
    "text": "we've already published some information in the cancer Journal but we'll continue to publish the information we find on",
    "start": "648560",
    "end": "653990"
  },
  {
    "text": "knowledge gaps and the closing of those gaps as time goes on and of course as we",
    "start": "653990",
    "end": "659390"
  },
  {
    "text": "all know as you move from patient engagement and retention it you do this on social and things like",
    "start": "659390",
    "end": "665190"
  },
  {
    "text": "right track we also want to make sure we're learning how to apply it in a really thoughtful way to the patient",
    "start": "665190",
    "end": "670770"
  },
  {
    "text": "registries now the second work stream that Gabriel isolate we'll be sharing",
    "start": "670770",
    "end": "675930"
  },
  {
    "text": "with you today is around data and analytics and the problem we were solving for here was the data sets are",
    "start": "675930",
    "end": "683730"
  },
  {
    "text": "very scattered often siloed although really as Gabriel will share with you many of them are starting to emerge and",
    "start": "683730",
    "end": "690240"
  },
  {
    "text": "come together which is a great thing we also understand that a lot of times if you bring in AI and machine learning",
    "start": "690240",
    "end": "696600"
  },
  {
    "text": "companies and you frame the use case you can again keep that aggregation moving",
    "start": "696600",
    "end": "701820"
  },
  {
    "text": "and you can solve for many of the questions that our patients and other people in the ecosystem have so today",
    "start": "701820",
    "end": "709230"
  },
  {
    "text": "what Gabriel will be sharing with you is an amazing amount of one of the views put into understanding the full oncology",
    "start": "709230",
    "end": "716610"
  },
  {
    "text": "landscape where are these data sets what exactly is in them but also really exciting is also looking at the AI",
    "start": "716610",
    "end": "723420"
  },
  {
    "text": "companies where are they what are they working for so that you can start to apply these two things together data as",
    "start": "723420",
    "end": "730440"
  },
  {
    "text": "well as the AI companies as well as who can fund these different programs in addition we also have an HP X that you",
    "start": "730440",
    "end": "737850"
  },
  {
    "text": "think they'll look at called the answer fund where we show you how the MMRF took one stab at analyzing its compass data",
    "start": "737850",
    "end": "745490"
  },
  {
    "text": "that you might find interesting and then Gabriel will be doing a workshop on data",
    "start": "745490",
    "end": "750840"
  },
  {
    "text": "analytics in the first quarter of next year as well the third work stream that",
    "start": "750840",
    "end": "756930"
  },
  {
    "text": "we talked about then was clinical trials and the problem we were solving for here which we all know is the inefficiency",
    "start": "756930",
    "end": "762680"
  },
  {
    "text": "20% don't fail to enroll 80% are delayed and as we move through the immunotherapy",
    "start": "762680",
    "end": "769890"
  },
  {
    "text": "space we've all seen the articles of a lot of opportunity and drugs but perhaps",
    "start": "769890",
    "end": "775170"
  },
  {
    "text": "too few patients so one area we were asked to work on a bit craft was",
    "start": "775170",
    "end": "780560"
  },
  {
    "text": "evaluating and really studying platform trials which are such an exciting place to be and we all know the beautiful work",
    "start": "780560",
    "end": "787560"
  },
  {
    "text": "that's been done by people like Laura Esserman or the B AML study that's been going on or long nap",
    "start": "787560",
    "end": "794490"
  },
  {
    "text": "so what we decided to do is getting all of their wisdom was to actually also",
    "start": "794490",
    "end": "799560"
  },
  {
    "text": "look at a number of platform trials that were going on real time right now and I",
    "start": "799560",
    "end": "805050"
  },
  {
    "text": "really do want to thank the warriors that actually work with us every week chief medical officers in this space to",
    "start": "805050",
    "end": "811500"
  },
  {
    "text": "share their information their timelines their data so we could understand beyond the performance indices around these",
    "start": "811500",
    "end": "818430"
  },
  {
    "text": "studies so that was Ryan Alexander on GPM agile Daniel's player on my drug and",
    "start": "818430",
    "end": "823530"
  },
  {
    "text": "Victoria Maddox on precision promise thanks to their thoughtfulness we really",
    "start": "823530",
    "end": "828600"
  },
  {
    "text": "work with them to say here are the four challenges we see in working on master",
    "start": "828600",
    "end": "835230"
  },
  {
    "text": "protocols and we'll be publishing that information and bringing it to an fda",
    "start": "835230",
    "end": "840270"
  },
  {
    "text": "meeting as well and it's interesting too because we're also finding this in the i/o space and CRI was great at working",
    "start": "840270",
    "end": "846900"
  },
  {
    "text": "with us on this project as well so you'll start to see where we move in",
    "start": "846900",
    "end": "852570"
  },
  {
    "start": "849000",
    "end": "849000"
  },
  {
    "text": "terms of solutions to platform trials and as we do that we're also continuing",
    "start": "852570",
    "end": "858120"
  },
  {
    "text": "to work on our fourth work stream this work stream is really chaired by Richard in myself which is the venture space we",
    "start": "858120",
    "end": "865530"
  },
  {
    "text": "all know that there's a lot of money going into healthcare today which is a great thing whether it's coming from",
    "start": "865530",
    "end": "871350"
  },
  {
    "text": "philanthropy into amc's but we also know that there's a lot of really new and",
    "start": "871350",
    "end": "877980"
  },
  {
    "text": "exciting models starting to appear in venture so we're familiar with what",
    "start": "877980",
    "end": "883500"
  },
  {
    "text": "happened with cystic fibrosis but there's also a great model being supported by JDRF that we've been",
    "start": "883500",
    "end": "890040"
  },
  {
    "text": "following we look at the for-profit models like silas and endeavor cancer",
    "start": "890040",
    "end": "895560"
  },
  {
    "text": "mega funds with people like Andrew Lowe but we've also been studying all the funds from UBS so the ones being done at",
    "start": "895560",
    "end": "901800"
  },
  {
    "text": "the academic centers like being a Farber so what Richard and I will be doing is",
    "start": "901800",
    "end": "906990"
  },
  {
    "text": "hosting an event in the first quarter really studying all of the venture approaches identifying the best",
    "start": "906990",
    "end": "913320"
  },
  {
    "text": "practices in the space but then also in an exciting way looking for areas where funds have not yet been identified and",
    "start": "913320",
    "end": "920190"
  },
  {
    "text": "how we can move forward so when you look at the problem we're solving on the venture piece and a media",
    "start": "920190",
    "end": "926140"
  },
  {
    "text": "effort of how to import with some of the disease foundations real time to get their venture philanthropy up and",
    "start": "926140",
    "end": "932620"
  },
  {
    "text": "running in a really rapid way it could be to the JDRF model a separate LLC and",
    "start": "932620",
    "end": "937630"
  },
  {
    "text": "then simultaneously moving into the first quarter really looking at some of these novel fund ideas that are out",
    "start": "937630",
    "end": "943990"
  },
  {
    "text": "there and pushing those forward as well so what you saw from all of this was for",
    "start": "943990",
    "end": "950260"
  },
  {
    "start": "949000",
    "end": "949000"
  },
  {
    "text": "work streams highly integrated and the way we do a lot of this work is by",
    "start": "950260",
    "end": "956440"
  },
  {
    "text": "constantly looking for what's going on in the ecosystem and trying to bring as many groups as we can together in",
    "start": "956440",
    "end": "962880"
  },
  {
    "text": "oncology but across a number of diseases and Richard and I saw this firsthand the week of Labor Day where we hosted our",
    "start": "962880",
    "end": "969280"
  },
  {
    "text": "first executive education program to a somewhat sellout crowd up here which was so rewarding these were the case studies",
    "start": "969280",
    "end": "976540"
  },
  {
    "text": "we looked at answer funds impact investing platform trials from the GBM",
    "start": "976540",
    "end": "982360"
  },
  {
    "text": "agile payer programs and all of that was taught up here across many different",
    "start": "982360",
    "end": "988570"
  },
  {
    "text": "people in the ecosystem so we had pharma companies biotech companies payers academic centers and everybody came up",
    "start": "988570",
    "end": "995350"
  },
  {
    "text": "with a precision medicine problem that they were trying to solve for in the executive education space I will tell",
    "start": "995350",
    "end": "1001320"
  },
  {
    "text": "you a key taking takeaway from that event was how much everybody was struggling on the things inside and it",
    "start": "1001320",
    "end": "1007710"
  },
  {
    "text": "was one of the reasons that we knew this effort was bastard QH would be so exciting for all of you no matter where",
    "start": "1007710",
    "end": "1013770"
  },
  {
    "text": "you are in precision medicine you have to be able to figure out the data elements of it so that makes me",
    "start": "1013770",
    "end": "1020790"
  },
  {
    "text": "incredibly excited to share with you that Gabriel Eichler is joining us and",
    "start": "1020790",
    "end": "1026310"
  },
  {
    "text": "he chairs as I said the the data work stream with us he has such a great",
    "start": "1026310",
    "end": "1031350"
  },
  {
    "text": "background having founded Oak Health Partners but also having worked at GN s and patients like me and I've had the",
    "start": "1031350",
    "end": "1038069"
  },
  {
    "text": "honor of working side-by-side with them for the past year and it's a really treat a big treat to see all the work",
    "start": "1038070",
    "end": "1043829"
  },
  {
    "text": "that he's done so thank you again for all of your time I hope that you stay",
    "start": "1043829",
    "end": "1049170"
  },
  {
    "text": "interested and you continue to follow us at HBS health and if we can answer",
    "start": "1049170",
    "end": "1054780"
  },
  {
    "text": "questions at the end I look forward to that as well and with that I'll turn it over to Gabriel thank you so much Kathy pleasure to be",
    "start": "1054780",
    "end": "1062760"
  },
  {
    "text": "here today everybody and looking forward to presenting some of the work that I've been doing through most of this year I'm",
    "start": "1062760",
    "end": "1069390"
  },
  {
    "text": "going to start off by talking about some of the work we've done on real-world data landscapes and where the real world",
    "start": "1069390",
    "end": "1074670"
  },
  {
    "text": "data resides currently in the ecosystem and then the latter part of my talk will focus on some of the work we've done",
    "start": "1074670",
    "end": "1079950"
  },
  {
    "text": "looking at real world data and analytics companies and both the applications they're working on as well as sort of",
    "start": "1079950",
    "end": "1086880"
  },
  {
    "text": "looking at a bit of a who's-who in that space first off just to set the stage a",
    "start": "1086880",
    "end": "1092160"
  },
  {
    "text": "bit you know I want to make note here that I think a useful recipe for any practitioner in this space is to think",
    "start": "1092160",
    "end": "1098820"
  },
  {
    "text": "about the integration of three primary ingredients as a recipe for building out",
    "start": "1098820",
    "end": "1103830"
  },
  {
    "text": "data-driven insights the first is of course a well-defined question that is answerable given the data you have",
    "start": "1103830",
    "end": "1110370"
  },
  {
    "text": "access to it is specific as many aspects of that and we're actually not going to focus on the questions I today but of",
    "start": "1110370",
    "end": "1116760"
  },
  {
    "text": "course that's some of the most important aspects of what we do the second part is a data source and a rich data source",
    "start": "1116760",
    "end": "1122760"
  },
  {
    "text": "that can be you know has the resolution and the fidelity to be able to answer",
    "start": "1122760",
    "end": "1128850"
  },
  {
    "text": "the questions at hand and the third is of course an analytical methodology which obviously AI and machine learning",
    "start": "1128850",
    "end": "1134970"
  },
  {
    "text": "have become increasingly interesting sort of development and areas of innovation but there's also this",
    "start": "1134970",
    "end": "1141480"
  },
  {
    "text": "tremendous body of literature around statistics and other types of analytical",
    "start": "1141480",
    "end": "1146850"
  },
  {
    "text": "methodologies that you know oftentimes are quite aptly applied as well and what comes out of this recipe interesting Lee",
    "start": "1146850",
    "end": "1152790"
  },
  {
    "text": "is not answers rather I should emphasize here it is hypotheses so oftentimes",
    "start": "1152790",
    "end": "1157830"
  },
  {
    "text": "people want to look to data and take answers directly out of retrospective data I think that that is very possibly",
    "start": "1157830",
    "end": "1164670"
  },
  {
    "text": "a path that we can be aiming for but ultimately at this day and age where we are is that the data can invest yield",
    "start": "1164670",
    "end": "1171930"
  },
  {
    "text": "hypotheses and that in and of itself is valuable in reducing the possible set of",
    "start": "1171930",
    "end": "1177570"
  },
  {
    "text": "hypotheses that can be tested and helping to suggest new key hypotheses but I just want emphasize here nobody",
    "start": "1177570",
    "end": "1183330"
  },
  {
    "text": "walks away from these projects with the answers to everything that they would dream for rather a new place to start in",
    "start": "1183330",
    "end": "1190560"
  },
  {
    "start": "1189000",
    "end": "1189000"
  },
  {
    "text": "2016 we do some work on a dated landscape that I actually inherited looking at the",
    "start": "1190560",
    "end": "1196200"
  },
  {
    "text": "sources of real-world data you know across the ecosystem of oncology I'm",
    "start": "1196200",
    "end": "1201660"
  },
  {
    "text": "also a bigger version of the slide graphic contained here in the focus of",
    "start": "1201660",
    "end": "1206820"
  },
  {
    "text": "that was looking at the longitude analogy and openness and the funding sources for those datasets and of course we looked at datasets across the",
    "start": "1206820",
    "end": "1213660"
  },
  {
    "text": "spectrum of all sizes and types but since that landscape is done obviously there's been a tremendous amount of",
    "start": "1213660",
    "end": "1219660"
  },
  {
    "text": "additional momentum in the space new data assets are becoming available on a commercial and open scales there's been",
    "start": "1219660",
    "end": "1226320"
  },
  {
    "text": "new registries and platform trials that are burgeoned and created additional data and then we're also seeing a",
    "start": "1226320",
    "end": "1232470"
  },
  {
    "text": "tremendous amount of investment go into this space and so we realized in late 2017 you'll be a phenomenal thing to try",
    "start": "1232470",
    "end": "1238740"
  },
  {
    "text": "to update this landscape and we visit some of these same themes so in the 2018 landscape we focus a little bit",
    "start": "1238740",
    "end": "1245250"
  },
  {
    "text": "differently looking at not per se the same aspects of the 2016 landscape but",
    "start": "1245250",
    "end": "1251070"
  },
  {
    "text": "rather we are really interested to know who is absolutely integrating molecular",
    "start": "1251070",
    "end": "1256170"
  },
  {
    "text": "clinical and longitudinal data into single data assets because that we feel",
    "start": "1256170",
    "end": "1262140"
  },
  {
    "text": "like is much more of the complete picture that's required for a lot of available insights people are seeking",
    "start": "1262140",
    "end": "1267500"
  },
  {
    "text": "likewise we wanted to look at and explore how accessible and linkable these types of data assets were and then",
    "start": "1267500",
    "end": "1275040"
  },
  {
    "text": "we also tried to focus on the data assets that were the most significant in size or focus and really did not focus",
    "start": "1275040",
    "end": "1281550"
  },
  {
    "text": "on two smaller assets or the emerging assets quite as much as the 2016 landscape so as I said this is some of",
    "start": "1281550",
    "end": "1288570"
  },
  {
    "text": "the work that came out of the 2016 landscape here that you're seeing this work is available as well on the website",
    "start": "1288570",
    "end": "1294450"
  },
  {
    "text": "of the craft program if anybody left a copy of this landscape and this was",
    "start": "1294450",
    "end": "1299460"
  },
  {
    "text": "actually what we came up with after doing the 2018 landscape and I want to call your attention to a few aspects of",
    "start": "1299460",
    "end": "1305460"
  },
  {
    "text": "what you're seeing here first of all the horizontal access is looking at the degree of dimensionality and curation in",
    "start": "1305460",
    "end": "1312480"
  },
  {
    "text": "the data assets you know as many people have experienced and relate to the data",
    "start": "1312480",
    "end": "1319140"
  },
  {
    "text": "coming out of a clinical environment from the EMR is typically very unstructured and difficult to analyze",
    "start": "1319140",
    "end": "1325110"
  },
  {
    "text": "through computational means so the degree of curation and as well the degree of integration of multiple",
    "start": "1325110",
    "end": "1330720"
  },
  {
    "text": "data types and streams is essential to having a really actionable and valuable data asset and we're seeing here on the",
    "start": "1330720",
    "end": "1337109"
  },
  {
    "text": "horizontal that we've played out and explored that spectrum on the vertical we're really looking at how are these",
    "start": "1337109",
    "end": "1343139"
  },
  {
    "text": "datasets becoming accessible to various partners and I wanted to call attention here that the horizontal where the",
    "start": "1343139",
    "end": "1349679"
  },
  {
    "text": "horizontal and vertical axes meet obviously above that line those data",
    "start": "1349679",
    "end": "1354779"
  },
  {
    "text": "assets are increasingly publicly available the reason that I'm drawing a",
    "start": "1354779",
    "end": "1360179"
  },
  {
    "text": "distinction here among those on the top of the chart versus those in the bottom as to whether or not the injury even",
    "start": "1360179",
    "end": "1365999"
  },
  {
    "text": "commercially available so just because it's above the line doesn't mean it's free but it does mean that one could purchase it or one could engage with it",
    "start": "1365999",
    "end": "1372509"
  },
  {
    "text": "on a research setting in the right context and I think that that's some a nice dimension that we're seeing which",
    "start": "1372509",
    "end": "1377549"
  },
  {
    "text": "is that many of the data assets are increasingly becoming publicly available you've also note that the red borders",
    "start": "1377549",
    "end": "1384210"
  },
  {
    "text": "around the lines indicate whether these data assets are either linked or would",
    "start": "1384210",
    "end": "1389460"
  },
  {
    "text": "support the linkage to other data assets on a individual patient by patient level of course in a HIPAA compliant and Phai",
    "start": "1389460",
    "end": "1396720"
  },
  {
    "text": "sensitive approach and then lastly I'll point out on this which is interesting",
    "start": "1396720",
    "end": "1402359"
  },
  {
    "text": "is that we put a lot of the smaller very niche registries like BJ ml lung math I",
    "start": "1402359",
    "end": "1408090"
  },
  {
    "text": "Spy and mm ahrefs work all the way to the right hand side because those data assets are very very tailored to",
    "start": "1408090",
    "end": "1414389"
  },
  {
    "text": "specific diseases and the I would say focus on what they do leads us to feel",
    "start": "1414389",
    "end": "1419639"
  },
  {
    "text": "like they have very superior data assets with regard to their single diseases where's a lot of the large balls of flat",
    "start": "1419639",
    "end": "1426330"
  },
  {
    "text": "iron through IQ via and cancer link our general data assets that may have a lot",
    "start": "1426330",
    "end": "1432599"
  },
  {
    "text": "more all-comers and you know those data assets can also be valuable but they're just not quite as specific and niche",
    "start": "1432599",
    "end": "1438960"
  },
  {
    "text": "oriented as as others one learning I wanted to share here in talking to you",
    "start": "1438960",
    "end": "1446009"
  },
  {
    "start": "1442000",
    "end": "1442000"
  },
  {
    "text": "know upwards of 50 AMC's for this project and many organizations that are collecting data is that many people",
    "start": "1446009",
    "end": "1451470"
  },
  {
    "text": "think about AMC's is having you know let's say a flower shop worth of data that and anybody should be able to come",
    "start": "1451470",
    "end": "1457799"
  },
  {
    "text": "in there as a researcher with a legitimate question and pluck off some of the data and have a bouquet of that data to analyze and work",
    "start": "1457799",
    "end": "1464340"
  },
  {
    "text": "with as they need and neat accessible clean and ready to go data assets the",
    "start": "1464340",
    "end": "1469500"
  },
  {
    "text": "reality though is that I think that we should think about AMC data assets from a different perspective and the analogy",
    "start": "1469500",
    "end": "1475200"
  },
  {
    "text": "I use here that it's like a field of wildflowers yes all the flowers are present but the collection collation",
    "start": "1475200",
    "end": "1481680"
  },
  {
    "text": "cleaning and preparation of the actual flowers is actually a time-consuming and",
    "start": "1481680",
    "end": "1486750"
  },
  {
    "text": "expensive effort and I think that is important that we both respect and appreciate that challenge and",
    "start": "1486750",
    "end": "1492300"
  },
  {
    "text": "acknowledge that you know funding is necessary sometimes on the mg side in order to cover the cost of reaping and",
    "start": "1492300",
    "end": "1499170"
  },
  {
    "text": "harvesting those those resources for the purpose of research questions like the hours often a few observations I want to",
    "start": "1499170",
    "end": "1507720"
  },
  {
    "start": "1506000",
    "end": "1506000"
  },
  {
    "text": "just share as well on the 2018 beta landscape and I'll go through these rather quickly because we have a lot more to get through here the first is",
    "start": "1507720",
    "end": "1514380"
  },
  {
    "text": "that between 2016 and the 2018 landscape we saw a median improvement in size in",
    "start": "1514380",
    "end": "1519450"
  },
  {
    "text": "the data assets of about 25 percent and many data assets now are exceeding a million patients in size likewise I",
    "start": "1519450",
    "end": "1527010"
  },
  {
    "text": "think the curation game has been well defined both through the efforts of folks like Flatiron and many other",
    "start": "1527010",
    "end": "1533370"
  },
  {
    "text": "organizations that are investing in that space and that curation has dramatically improved the value and the accessibility",
    "start": "1533370",
    "end": "1539340"
  },
  {
    "text": "of the datasets that they've created likewise the patient registries I think",
    "start": "1539340",
    "end": "1545370"
  },
  {
    "text": "also play a very strong role as I mentioned two slides prior in terms of sharing and linking models we think that",
    "start": "1545370",
    "end": "1552900"
  },
  {
    "text": "this is actually a tremendously exciting and rich area that many organizations are acknowledging that they may have the",
    "start": "1552900",
    "end": "1559890"
  },
  {
    "text": "keys to an important component of the patient care and journey that these patients go on but they typically don't",
    "start": "1559890",
    "end": "1566370"
  },
  {
    "text": "have all the data and so acknowledgement of the linking and the contractual requirements that that entails is I",
    "start": "1566370",
    "end": "1572520"
  },
  {
    "text": "think a real positive progress on the spacing that we're seeing several models listed here that I want to just call out",
    "start": "1572520",
    "end": "1579650"
  },
  {
    "text": "likewise when we were engaging with these organizations we asked them about their willingness and ability to share",
    "start": "1579650",
    "end": "1584970"
  },
  {
    "text": "and to link their data assets and from my I'd say informal view of this space",
    "start": "1584970",
    "end": "1590160"
  },
  {
    "text": "I'm increasingly noting that these companies are acknowledging that they have to would be willing to and need to engage",
    "start": "1590160",
    "end": "1596620"
  },
  {
    "text": "in linking activities and so you know there may sometimes be technical and privacy hurdles that are hard to",
    "start": "1596620",
    "end": "1602640"
  },
  {
    "text": "overcome especially for a long term date asset that may not have baked that into the consent but for many others this is",
    "start": "1602640",
    "end": "1609700"
  },
  {
    "text": "something that they're quickly moving towards and something I think that will continue and then lastly on this slide I",
    "start": "1609700",
    "end": "1616510"
  },
  {
    "text": "want to point out there's still many frontiers in this space which I think are tremendously exciting I think that",
    "start": "1616510",
    "end": "1622090"
  },
  {
    "text": "the linkage of these data assets to real-world specimen whether they be blood or tissue is in a really exciting",
    "start": "1622090",
    "end": "1628210"
  },
  {
    "text": "frontier that would enable not just the enable the better archive and retrieval",
    "start": "1628210",
    "end": "1634960"
  },
  {
    "text": "of specimen as well as more real Studies on actual specimen for the creation of",
    "start": "1634960",
    "end": "1640630"
  },
  {
    "text": "diagnostics and other types of odd disease models I think the collection of",
    "start": "1640630",
    "end": "1645880"
  },
  {
    "text": "raw imaging including datasets that could be used in radiomics applications is also extremely exciting both in terms",
    "start": "1645880",
    "end": "1652810"
  },
  {
    "text": "of pathology imaging as well as radiation imaging that that's used of",
    "start": "1652810",
    "end": "1658540"
  },
  {
    "text": "physiology patient recontact rights are incredibly important oftentimes patients",
    "start": "1658540",
    "end": "1664840"
  },
  {
    "text": "you know we can build analytics and get tremendous results but there's always a",
    "start": "1664840",
    "end": "1669910"
  },
  {
    "text": "handful of patients that don't quite fit into the model and so one always wondered which are those patients and why those patients aren't being modelled",
    "start": "1669910",
    "end": "1676540"
  },
  {
    "text": "correctly by the algorithm and one source of that error is oftentimes where the data was Mis collected or not",
    "start": "1676540",
    "end": "1682240"
  },
  {
    "text": "annotated properly for some caveats and so the patient recontact rights are a tremendous opportunity to be able to",
    "start": "1682240",
    "end": "1689920"
  },
  {
    "text": "engage with the physician and the patient's more and in ensuring that we do this in a compliant and appropriate",
    "start": "1689920",
    "end": "1696760"
  },
  {
    "text": "fashion is one that I think is a frontier of much research and innovation and then lastly I want to point to some",
    "start": "1696760",
    "end": "1703060"
  },
  {
    "text": "improvements of data standards which I think are coming and I think it's a real opportunity for improvement and",
    "start": "1703060",
    "end": "1708250"
  },
  {
    "text": "something that we've been thinking a lot here about how we can improve the standards of real-world data so that",
    "start": "1708250",
    "end": "1713440"
  },
  {
    "text": "these data assets can be more easily combined and brought in touch with each other",
    "start": "1713440",
    "end": "1719520"
  },
  {
    "text": "I wanted to shift gears if I can to some of the aspects and work we've been doing",
    "start": "1720100",
    "end": "1725200"
  },
  {
    "text": "on the available data landscapes this space has been tremendously exciting to watch from the outside there",
    "start": "1725200",
    "end": "1732230"
  },
  {
    "start": "1731000",
    "end": "1731000"
  },
  {
    "text": "participate in um you know obviously there's been real excitement on the",
    "start": "1732230",
    "end": "1737360"
  },
  {
    "text": "headlines of this I'd say people are holding a tremendous promise for what AI can do to healthcare I think though that",
    "start": "1737360",
    "end": "1744140"
  },
  {
    "text": "you know the reality is is that we can get ahead of ourselves a little bit easily here and that there can often be",
    "start": "1744140",
    "end": "1749720"
  },
  {
    "text": "some excessive exuberance if you will or some hype that we need to acknowledge may be present and in the current",
    "start": "1749720",
    "end": "1757070"
  },
  {
    "text": "discussions today and we want to spend some time kind of parsing through what's out there saying who the leaders are and",
    "start": "1757070",
    "end": "1763280"
  },
  {
    "text": "what these folks are working on so as you can tell there's you know as Kathy pointed to a similar cloud of icons from",
    "start": "1763280",
    "end": "1772130"
  },
  {
    "text": "these organizations and logos there's a tremendous number of companies in this space that you most people on the call",
    "start": "1772130",
    "end": "1778580"
  },
  {
    "text": "haven't heard of at least some of the organizations on this slide and I wanted to spend some time helping you to",
    "start": "1778580",
    "end": "1784640"
  },
  {
    "text": "understand what it is that these organizations do and which ones may be emerging as the leaders in this next",
    "start": "1784640",
    "end": "1791000"
  },
  {
    "text": "generation of AI applications to healthcare so our objective here was to",
    "start": "1791000",
    "end": "1796460"
  },
  {
    "start": "1794000",
    "end": "1794000"
  },
  {
    "text": "really reach this core set of stakeholders of investors nonprofits researchers and hospitals payers and",
    "start": "1796460",
    "end": "1803000"
  },
  {
    "text": "patients to help them answer questions about you know where our advanced analytics like AI and machine learning",
    "start": "1803000",
    "end": "1809210"
  },
  {
    "text": "being most aptly applied who may be a suitable investment target that is really on a roll and and a company that",
    "start": "1809210",
    "end": "1816560"
  },
  {
    "text": "we should expect some exciting news out of in the coming years it is best to build by or to partner with these",
    "start": "1816560",
    "end": "1823190"
  },
  {
    "text": "organizations you know this is a big question about whether or not these innovations are best done within the",
    "start": "1823190",
    "end": "1828410"
  },
  {
    "text": "four walls of an organization or whether they're best done through partnership and then when the technologies may be",
    "start": "1828410",
    "end": "1835640"
  },
  {
    "text": "ready for real-world applications I think that there's a tremendous hurdle that we've seen in wet lab R&D with",
    "start": "1835640",
    "end": "1842960"
  },
  {
    "text": "regard to translational biology and translational clinical sciences and I think that in many ways health IT and",
    "start": "1842960",
    "end": "1849230"
  },
  {
    "text": "health technologies like this also have a similar hurdle of translated into the clinical environment and you know it's",
    "start": "1849230",
    "end": "1856370"
  },
  {
    "text": "always a question about what that hurdle looks like with any new modality and that's one that we're watching closely here at the craft",
    "start": "1856370",
    "end": "1861800"
  },
  {
    "text": "program so when we looked at this space we decided to break down the application",
    "start": "1861800",
    "end": "1867860"
  },
  {
    "start": "1863000",
    "end": "1863000"
  },
  {
    "text": "areas into a handful roughly six different use cases where AI machine",
    "start": "1867860",
    "end": "1873470"
  },
  {
    "text": "learning are being aptly applied obviously there's one about looking at",
    "start": "1873470",
    "end": "1878780"
  },
  {
    "text": "target identification biomarkers as well as some of the chemo and 4matic applications there's applications more",
    "start": "1878780",
    "end": "1884750"
  },
  {
    "text": "directly to the end and drug discovery preclinical research there's applications to introducing of the",
    "start": "1884750",
    "end": "1891920"
  },
  {
    "text": "identification of patients for clinical trials and then the downstream analysis of the results that come out of clinical",
    "start": "1891920",
    "end": "1898100"
  },
  {
    "text": "trials and then lastly there's applications to the clinical pathways and decision support that are required",
    "start": "1898100",
    "end": "1904550"
  },
  {
    "text": "in the clinic and then the population health and value-based care analytics that oftentimes are increasingly",
    "start": "1904550",
    "end": "1910520"
  },
  {
    "text": "becoming part of the conversation so I wanted to if I could spend some time",
    "start": "1910520",
    "end": "1915830"
  },
  {
    "text": "talking about these applications with these organizations I'll tell you what we did here we looked at about 46",
    "start": "1915830",
    "end": "1921830"
  },
  {
    "start": "1919000",
    "end": "1919000"
  },
  {
    "text": "companies across the space most of these companies are us-based but not entirely we pulled together list from wherever we",
    "start": "1921830",
    "end": "1929120"
  },
  {
    "text": "could find them on the internet on web searches on industry reports and came up",
    "start": "1929120",
    "end": "1934340"
  },
  {
    "text": "with this list of organizations doing interesting things we unfortunately recognized that the methodology we want",
    "start": "1934340",
    "end": "1940880"
  },
  {
    "text": "to use for analysis would it really work great for companies that were sort of",
    "start": "1940880",
    "end": "1946490"
  },
  {
    "text": "either too complex or too small and insufficiently annotated by what they do to really pull them up into this so I",
    "start": "1946490",
    "end": "1953510"
  },
  {
    "text": "acknowledge that there's organizations that we had trouble sort of parsing through and prioritizing in our analysis",
    "start": "1953510",
    "end": "1960410"
  },
  {
    "text": "but I'll show you what we did anyway with the other companies that 46 I listed on the prior slide we looked at",
    "start": "1960410",
    "end": "1966320"
  },
  {
    "start": "1965000",
    "end": "1965000"
  },
  {
    "text": "the degree to which these organizations were experiencing and demonstrating hallmarks of recent acceleration in",
    "start": "1966320",
    "end": "1974030"
  },
  {
    "text": "their business through region financing the percentage of job growth they've experienced over the past 12 months and",
    "start": "1974030",
    "end": "1980600"
  },
  {
    "text": "then the number or percentage of open positions that they have at the company and then of course we explored this",
    "start": "1980600",
    "end": "1988900"
  },
  {
    "text": "relative to the establishment metrics for these organizations the total number of publications which",
    "start": "1988900",
    "end": "1995460"
  },
  {
    "text": "they have the numbers of partners and customers which they speak publicly about and of course the total funding",
    "start": "1995460",
    "end": "2001010"
  },
  {
    "text": "which they've gotten to date and of course when you put this on to a two by two type matrix you can actually see",
    "start": "2001010",
    "end": "2007130"
  },
  {
    "text": "some interesting patterns emerge because of course there's companies that are the industry standards which are highly",
    "start": "2007130",
    "end": "2012410"
  },
  {
    "text": "established but really not accelerating so fast anymore and there's organizations which are emerging but not",
    "start": "2012410",
    "end": "2019400"
  },
  {
    "text": "necessarily established because they're really just coming out of the gate and accelerating early on but we think that",
    "start": "2019400",
    "end": "2024650"
  },
  {
    "text": "the companies up here which both have size critical mass and acceleration are",
    "start": "2024650",
    "end": "2029690"
  },
  {
    "text": "tremendously interesting because these are the companies that we think may be breaking out of the mold and really",
    "start": "2029690",
    "end": "2035780"
  },
  {
    "text": "innovating an exciting way that the market is realizing so when you put this all together we you know want to just",
    "start": "2035780",
    "end": "2042920"
  },
  {
    "start": "2040000",
    "end": "2040000"
  },
  {
    "text": "make a note of a few limitations here the first of which is that obviously this is very US focused we're quantifying the entire",
    "start": "2042920",
    "end": "2049580"
  },
  {
    "text": "organization and I break it down by capabilities but of course it's hard to do that this is a trailing indicator of",
    "start": "2049580",
    "end": "2055610"
  },
  {
    "text": "the company's data ascend of course as new news emerges these metrics may change dramatically",
    "start": "2055610",
    "end": "2061878"
  },
  {
    "text": "and then of course any real breakthroughs are sometimes hard to capture in this model but I'll show you what we found this is the landscape",
    "start": "2061879",
    "end": "2068148"
  },
  {
    "text": "that's put on that 2x2 matrix of the 46 companies which we spoke to again the",
    "start": "2068149",
    "end": "2074090"
  },
  {
    "text": "y-axis being the establishment and the percentile and then relative to that",
    "start": "2074090",
    "end": "2079550"
  },
  {
    "text": "cohort we also have the accelerating percentile of the same organizations and so you're seeing here interestingly not",
    "start": "2079550",
    "end": "2085878"
  },
  {
    "text": "surprisingly that there are a number of companies that are both in the upper left-hand quadrant and in the lower",
    "start": "2085879",
    "end": "2091908"
  },
  {
    "text": "right-hand quadrant which is you know as I said before uh somewhat to be expected because those are the typical modalities",
    "start": "2091909",
    "end": "2098780"
  },
  {
    "text": "of where the space would be and likewise we're seeing very few companies down in the lower left-hand corner which makes a",
    "start": "2098780",
    "end": "2104780"
  },
  {
    "text": "good sense because this is truly an industry which is growing and emerging and very exciting time and place for that on the flip side though the",
    "start": "2104780",
    "end": "2111800"
  },
  {
    "text": "organizations as I said before which are up here are the ones that are truly interesting from our perspective and",
    "start": "2111800",
    "end": "2117110"
  },
  {
    "text": "we'll be diving deep into on a case by case basis so if I look at the companies",
    "start": "2117110",
    "end": "2123380"
  },
  {
    "start": "2122000",
    "end": "2122000"
  },
  {
    "text": "that claim and speak about their work in biomarker and target IDs a few of them stand out and I want to",
    "start": "2123380",
    "end": "2129470"
  },
  {
    "text": "just call out some of those organizations if I can in this sort of a format and I'll go through all the applications in the same way so the",
    "start": "2129470",
    "end": "2136430"
  },
  {
    "text": "first is Tempest which many folks have probably read about this is a company founded by the Groupon founder eric",
    "start": "2136430",
    "end": "2142670"
  },
  {
    "text": "letovsky and he has raised a tremendous amount of money at what now exceeds a",
    "start": "2142670",
    "end": "2148250"
  },
  {
    "text": "two billion dollar valuation he along with precision health AI have licensed the cancer link data asset from ASCO and",
    "start": "2148250",
    "end": "2155000"
  },
  {
    "text": "have been asked to commercialize it with many organizations they partnered with",
    "start": "2155000",
    "end": "2160250"
  },
  {
    "text": "hundreds of hospitals and they claim to have over 2 million clinical records at their hands and disposal musicians all",
    "start": "2160250",
    "end": "2167000"
  },
  {
    "text": "the molecular data which they generate in-house now at Tempest so a very exciting model and one that I think is",
    "start": "2167000",
    "end": "2172160"
  },
  {
    "text": "turning a lot of heads because of its momentum but never a day I another organization which has I think reached a",
    "start": "2172160",
    "end": "2178010"
  },
  {
    "text": "lot of sort of minds of folks probably on the line and people are hearing a lot about they've raised a tremendous amount",
    "start": "2178010",
    "end": "2184910"
  },
  {
    "text": "of money as well and have exceeded the two billion dollar valuation as well which is an incredibly high threshold",
    "start": "2184910",
    "end": "2190430"
  },
  {
    "text": "for such a young company they were awarded some accolades from the World Economic Forum recently and they are",
    "start": "2190430",
    "end": "2197270"
  },
  {
    "text": "growing inside tremendously fast with about 140 page job people in the organization with a seventy five percent",
    "start": "2197270",
    "end": "2203300"
  },
  {
    "text": "year-over-year growth rate the third one I would actually be surprised if everybody's heard about but an",
    "start": "2203300",
    "end": "2209360"
  },
  {
    "text": "interesting one called recursion Pharma this company partners with all sorts of industry organizations including fantasy",
    "start": "2209360",
    "end": "2216230"
  },
  {
    "text": "and academics like UCSD and they raised what you know by comparison looks like a",
    "start": "2216230",
    "end": "2221780"
  },
  {
    "text": "paltry amount of only 105 million dollars with a 60 million dollar raise in October of last year but obviously",
    "start": "2221780",
    "end": "2228140"
  },
  {
    "text": "this is a company which has some real momentum and we're keeping an eye on as well in terms of drug discovery",
    "start": "2228140",
    "end": "2234920"
  },
  {
    "start": "2233000",
    "end": "2233000"
  },
  {
    "text": "companies and these are companies again that are attempting to make true breakthrough work in regard to end and",
    "start": "2234920",
    "end": "2245390"
  },
  {
    "text": "bioinformatics chemo informatics and preclinical work I want to call out a few of them here including Adam wise",
    "start": "2245390",
    "end": "2252220"
  },
  {
    "text": "which is a you know company that prides itself on making new molecules for the",
    "start": "2252220",
    "end": "2258470"
  },
  {
    "text": "hardest targets the so called undruggable they were basically featured on a list of the disrupt 100 and so it's nice to",
    "start": "2258470",
    "end": "2265070"
  },
  {
    "text": "see that they actually follow that on the high end of our list given this use case they're actually quite small in",
    "start": "2265070",
    "end": "2271370"
  },
  {
    "text": "size under 30 people and they have though a tremendously rich growth rate of 150 percent year-on-year",
    "start": "2271370",
    "end": "2277480"
  },
  {
    "text": "deep genomics also interesting company of modest size 30 employees and they've",
    "start": "2277480",
    "end": "2282710"
  },
  {
    "text": "raised again you know around 13 million dollars last year but interestingly they're getting money from pretty",
    "start": "2282710",
    "end": "2289370"
  },
  {
    "text": "top-tier investors like Khosla Ventures among other top-rated organizations and",
    "start": "2289370",
    "end": "2295130"
  },
  {
    "text": "then lastly on 2xr I'm not sure how to say that is an intelligence driven drug",
    "start": "2295130",
    "end": "2300650"
  },
  {
    "text": "discovery company also quite young also raising modest amounts of money given the space but again from Softbank and",
    "start": "2300650",
    "end": "2307580"
  },
  {
    "text": "andreessen horowitz which are both top-tier tech and healthcare investors they have pretty impressive and",
    "start": "2307580",
    "end": "2314060"
  },
  {
    "text": "ambitious bio and chemo informatics applications which they're developing and again a modest size of employees but",
    "start": "2314060",
    "end": "2320030"
  },
  {
    "text": "given how they're approaching it and be interested they have garnered from top",
    "start": "2320030",
    "end": "2325340"
  },
  {
    "text": "to your investors in the competitive space I'm also quite interested to see how they shake out in the coming years",
    "start": "2325340",
    "end": "2331840"
  },
  {
    "start": "2331000",
    "end": "2331000"
  },
  {
    "text": "an application as I mentioned before of interest and I want to just call it one company here in particular is around",
    "start": "2331840",
    "end": "2337760"
  },
  {
    "text": "clinical trial patient ID and this is one of these breakthrough technologies which is trying to integrate both",
    "start": "2337760",
    "end": "2344810"
  },
  {
    "text": "genomic signatures with facial recognition technologies to identify patients with rare diseases often times",
    "start": "2344810",
    "end": "2352040"
  },
  {
    "text": "those rare diseases can manifest themselves in skin color or facial structure in the form of the and they",
    "start": "2352040",
    "end": "2358370"
  },
  {
    "text": "are partnering with all sorts of organizations globally actually on trying to bring this technology to bear they've been partnering with many",
    "start": "2358370",
    "end": "2365090"
  },
  {
    "text": "genomic organizations doing a lot of work in that space and I think it's an incredibly exciting and innovative",
    "start": "2365090",
    "end": "2370520"
  },
  {
    "text": "platform and you know the jury's still out whether they're going to be able to translate that into some real practical",
    "start": "2370520",
    "end": "2376880"
  },
  {
    "text": "applications but at least for the clinical trial IV side this could be quite interesting in terms of clinical",
    "start": "2376880",
    "end": "2384050"
  },
  {
    "start": "2382000",
    "end": "2382000"
  },
  {
    "text": "trial and the houses companies on to that I want to call out here in particular where AI cure and new Medi a",
    "start": "2384050",
    "end": "2390230"
  },
  {
    "text": "I cure was again nicely C and my research leaned on i 100 list as one of the most exciting",
    "start": "2390230",
    "end": "2397080"
  },
  {
    "text": "companies in this space modest trick the employees growing 30% year over year and new many has a series of applications",
    "start": "2397080",
    "end": "2403890"
  },
  {
    "text": "that they work on but part of that is actually looking at clinical trials and I want to call them out here because",
    "start": "2403890",
    "end": "2409500"
  },
  {
    "text": "they've landed a whole bunch of really innovative partners through Allegan",
    "start": "2409500",
    "end": "2414560"
  },
  {
    "text": "Astellas bi Yale and Brigham Women's Hospital and they have a tremendous",
    "start": "2414560",
    "end": "2419580"
  },
  {
    "text": "amount of thought leadership published from both their founders and their partners would the technology their",
    "start": "2419580",
    "end": "2425070"
  },
  {
    "text": "license out of a tool buttes lab at Stanford some of the companies on the",
    "start": "2425070",
    "end": "2431820"
  },
  {
    "start": "2429000",
    "end": "2429000"
  },
  {
    "text": "clinical pathways and decision support side that I wanted to call out one of which is microbio Tech which has you",
    "start": "2431820",
    "end": "2438660"
  },
  {
    "text": "know really founded itself around trying to deliver precision cancer treatment they had a pretty large raise in the",
    "start": "2438660",
    "end": "2446120"
  },
  {
    "text": "forty million dollar range earlier this summer and they as well have been working with the juggernaut Glen mark",
    "start": "2446120",
    "end": "2452700"
  },
  {
    "text": "Pharma out of India you know they have been growing larger than 25 percent year-over-year which is exciting",
    "start": "2452700",
    "end": "2459930"
  },
  {
    "text": "and then lastly wishing next code which you know has I think probably takes the list for the highest amount of money",
    "start": "2459930",
    "end": "2466080"
  },
  {
    "text": "raised by any company on this list at two hundred and forty million dollars around a year ago as of now and they of",
    "start": "2466080",
    "end": "2473010"
  },
  {
    "text": "course were also noted as when a Fast Company 10 most innovative companies so I think that that's also a company to be",
    "start": "2473010",
    "end": "2479130"
  },
  {
    "text": "watching over the coming years as well I think lastly on this list I wanted to go",
    "start": "2479130",
    "end": "2485970"
  },
  {
    "text": "through was two companies both coda and shift coda is a real-world data and",
    "start": "2485970",
    "end": "2492690"
  },
  {
    "text": "analytics company they were actually featured on the data analytics on the data landscape that I showed earlier in",
    "start": "2492690",
    "end": "2498240"
  },
  {
    "text": "the call coda has raised 40 million dollars and really has been I'd say one",
    "start": "2498240",
    "end": "2505170"
  },
  {
    "text": "of the leaders in the real-world data space partnering with hospitals structuring their data and helping to",
    "start": "2505170",
    "end": "2510690"
  },
  {
    "text": "make it accessible for downstream analytics and then also integrating analytics as well and so they do a lot",
    "start": "2510690",
    "end": "2517470"
  },
  {
    "text": "of work around population health and value-based care analytics as part of their own offerings and lastly shift",
    "start": "2517470",
    "end": "2524250"
  },
  {
    "text": "which initially was in our analysis when we started this work but then it was acquired my metadata we left them at an",
    "start": "2524250",
    "end": "2530100"
  },
  {
    "text": "independent organization to call that for now you know they were acquired in June of 2018 and they of course are",
    "start": "2530100",
    "end": "2536610"
  },
  {
    "text": "working with numerous organizations on analyzing and bringing in lytx to the",
    "start": "2536610",
    "end": "2541740"
  },
  {
    "text": "data sets of those organizations really exciting and beautiful product in",
    "start": "2541740",
    "end": "2548370"
  },
  {
    "start": "2547000",
    "end": "2547000"
  },
  {
    "text": "closing I wanted to share some sort of high-level observations about this landscape so the first off if you look",
    "start": "2548370",
    "end": "2554220"
  },
  {
    "text": "at the companies across the profile that I've analyzed there was about one point",
    "start": "2554220",
    "end": "2559980"
  },
  {
    "text": "four billion dollars raised by these companies in the landscape that's a tremendous amount and in the past 12",
    "start": "2559980",
    "end": "2565260"
  },
  {
    "text": "months on nearly half a billion dollars was raised which is very very exciting I think underscores how Polish investors",
    "start": "2565260",
    "end": "2571680"
  },
  {
    "text": "are about some major value creating outcomes whether those be exits acquisitions or other types of outcomes",
    "start": "2571680",
    "end": "2579360"
  },
  {
    "text": "for these companies it's also interesting because if you look back at some of the sides I've shared many",
    "start": "2579360",
    "end": "2585390"
  },
  {
    "text": "companies are applying their technology to multiple use cases suggesting at the core and capabilities of working with",
    "start": "2585390",
    "end": "2591480"
  },
  {
    "text": "these data and performing a on top of these data or you know applications",
    "start": "2591480",
    "end": "2597180"
  },
  {
    "text": "which can be used in many different ways and I think that you know these companies are still figuring out where",
    "start": "2597180",
    "end": "2602190"
  },
  {
    "text": "best to aim their tools and capabilities and that will continue to play out over the coming years it also suggests that",
    "start": "2602190",
    "end": "2608640"
  },
  {
    "text": "there's a diversity of business models here some of these organizations are developing their own drugs and we're partnering to develop drugs some are",
    "start": "2608640",
    "end": "2615000"
  },
  {
    "text": "offering services some are offering software and those different types of capabilities show that there's still",
    "start": "2615000",
    "end": "2620520"
  },
  {
    "text": "some you know let's say diversity and how these organizations are approaching",
    "start": "2620520",
    "end": "2625560"
  },
  {
    "text": "the business models they're trying to serve and then lastly I want to say that I think that there's really",
    "start": "2625560",
    "end": "2631610"
  },
  {
    "text": "paradigm-shifting potential here and what I mean by that is that these",
    "start": "2631610",
    "end": "2636840"
  },
  {
    "text": "companies are young I think they're going to take a few years to mature and to demonstrate what they can do and I",
    "start": "2636840",
    "end": "2642870"
  },
  {
    "text": "think that to the extent to which these companies have breakthroughs whether that be an approved drug whether that be",
    "start": "2642870",
    "end": "2648540"
  },
  {
    "text": "a drug that is rescued because a failed clinical trial gets reanalyzed a biomarker gets identified and that",
    "start": "2648540",
    "end": "2655020"
  },
  {
    "text": "drug then goes on to approval these are the type of stories that these organizations I think are apt to",
    "start": "2655020",
    "end": "2661760"
  },
  {
    "text": "creating and to be writing for themselves and that in the next few months we're going to start to see you",
    "start": "2661760",
    "end": "2668030"
  },
  {
    "text": "know the traction in the progress these organizations are making and I would not be surprised to see some real",
    "start": "2668030",
    "end": "2673790"
  },
  {
    "text": "breakthroughs on real disease rare disease Diagnostics pre clinical informatics trial designs and execution",
    "start": "2673790",
    "end": "2679880"
  },
  {
    "text": "as part of this and so I'm you know again I'm looking and I think that the reason I call this paradigm shifting is",
    "start": "2679880",
    "end": "2686060"
  },
  {
    "text": "because this would be a profound shift that many folks in the industry would recognize and as potentially a",
    "start": "2686060",
    "end": "2694370"
  },
  {
    "text": "redefinition of some dis activities if indeed it's demonstrated that advanced analytics can be so breakthrough and",
    "start": "2694370",
    "end": "2700960"
  },
  {
    "text": "transformative to to the objectives I want to just extend my thanks to the",
    "start": "2700960",
    "end": "2708620"
  },
  {
    "text": "folks that have been part of this work both on the craft program side on the faster cures side and then of course the",
    "start": "2708620",
    "end": "2715460"
  },
  {
    "text": "folks that have been so instrumental in creating the data landscape and the analytics landscape that we put together",
    "start": "2715460",
    "end": "2720800"
  },
  {
    "text": "here today and with that I'll turn it back over to Tanisha for questions",
    "start": "2720800",
    "end": "2728440"
  },
  {
    "text": "Gabriel and Kathy thank you so much I just want I know for me this has been such an amazing last half hour just",
    "start": "2728440",
    "end": "2737090"
  },
  {
    "text": "getting a sense for where you are in terms of the data and AI analytic landscape we had I want to thank folks",
    "start": "2737090",
    "end": "2743510"
  },
  {
    "text": "that had submitted questions earlier I have a few questions that have been pre submitted and so let me start there",
    "start": "2743510",
    "end": "2749560"
  },
  {
    "text": "let's start with the first question what are the actionable implications of all this information to the folks who are on",
    "start": "2749560",
    "end": "2756410"
  },
  {
    "text": "the line who are either funding conducting or investing in R&D and let's just begin with what an organization",
    "start": "2756410",
    "end": "2763160"
  },
  {
    "text": "like MMRF would do with this information so maybe Kathy if you could star that would be great sure yeah I'd love to so",
    "start": "2763160",
    "end": "2771110"
  },
  {
    "text": "I think you know having worked side by side with Gabriel and a few other of the AI companies you know with the huge",
    "start": "2771110",
    "end": "2778370"
  },
  {
    "text": "believers in the data space and understanding where data is you saw from the landscape that we have a a compass",
    "start": "2778370",
    "end": "2785990"
  },
  {
    "text": "study which is as Gabriel said is very focused on myeloma patients it's you",
    "start": "2785990",
    "end": "2791750"
  },
  {
    "text": "know a longitudinal genomic clinical but it's a hypothesis generating studies so in order for us to",
    "start": "2791750",
    "end": "2797510"
  },
  {
    "text": "validate what we want to keep working on we have to know where the other data sets are that are out there and when",
    "start": "2797510",
    "end": "2804230"
  },
  {
    "text": "we're trying to validate different areas we have to understand which AI company were working with so you know and we put",
    "start": "2804230",
    "end": "2810560"
  },
  {
    "text": "this together in a case study called the answer fund where you know if we're talking with patients they may want they",
    "start": "2810560",
    "end": "2816620"
  },
  {
    "text": "have questions about should I be on maintenance should I be on transplant and we have to work to understand you",
    "start": "2816620",
    "end": "2821930"
  },
  {
    "text": "know what should you do in your subject how do you make those decisions if we're working with academic centers it may be",
    "start": "2821930",
    "end": "2827480"
  },
  {
    "text": "more on the subtype space how do we build that out in the basic biology and with pharma targets biomarkers so we're",
    "start": "2827480",
    "end": "2834320"
  },
  {
    "text": "constantly scouring for new data we're constantly looking for new AI companies to be working with us and we work with a",
    "start": "2834320",
    "end": "2841010"
  },
  {
    "text": "number of the groups that are already on this page and then we've used a lot of this information we'll be launching an",
    "start": "2841010",
    "end": "2846500"
  },
  {
    "text": "entirely new program called cure cloud at the end of this year with a number of the partners that you'll have seen from",
    "start": "2846500",
    "end": "2853160"
  },
  {
    "text": "Gabriel's presentation and we're really excited to be that inclusive patient registry and even trying to get all of",
    "start": "2853160",
    "end": "2859400"
  },
  {
    "text": "us to move to the immune space so I'm happy to share all of that once all the contracts and things are signed but this",
    "start": "2859400",
    "end": "2867290"
  },
  {
    "text": "has been incredible for us to sit side-by-side and watch all this information come through and as I",
    "start": "2867290",
    "end": "2874460"
  },
  {
    "text": "mentioned before you know working with Gabriel were even HBS students trying to get through all of this data was was no",
    "start": "2874460",
    "end": "2880610"
  },
  {
    "text": "easy feat but it's the joy of being up here there's nothing more important to us than sharing you know what we're all",
    "start": "2880610",
    "end": "2887150"
  },
  {
    "text": "learning we've interviewed a lot of these companies but you know everybody has different ideas I think that's where",
    "start": "2887150",
    "end": "2893150"
  },
  {
    "text": "Gabriel's workshop will be really eye-opening to see how's everybody using an AI company data to solve a very",
    "start": "2893150",
    "end": "2899540"
  },
  {
    "text": "specific use case and problem whether you're a payer and academic center or a patient foundation very Abril anything",
    "start": "2899540",
    "end": "2907430"
  },
  {
    "text": "you want to add to that or elaborate on no I mean I think that Kathy's both very",
    "start": "2907430",
    "end": "2914150"
  },
  {
    "text": "aptly about how organizations like ours are using the data sets like this um you know I think that all organizations",
    "start": "2914150",
    "end": "2920920"
  },
  {
    "text": "especially philanthropy are trying to figure out their role in how they bring real world data into the",
    "start": "2920920",
    "end": "2926740"
  },
  {
    "text": "so they sponsor the collection and the analysis of it you know another role which I want to point out here that MMRF",
    "start": "2926740",
    "end": "2934180"
  },
  {
    "text": "has been a leader on and I think many other organizations are starting to see as well and I eluded this earlier that",
    "start": "2934180",
    "end": "2939480"
  },
  {
    "text": "there is no shortage of challenge in trying to define the right questions to",
    "start": "2939480",
    "end": "2945340"
  },
  {
    "text": "ask and I think that a lot of the book that MMRF has been doing and other",
    "start": "2945340",
    "end": "2950680"
  },
  {
    "text": "organizations are trying to follow in their footsteps has been around asking sort of defining",
    "start": "2950680",
    "end": "2956820"
  },
  {
    "text": "prioritizing and asking the key questions in their disease which are going to unlock the most progress in",
    "start": "2956820",
    "end": "2963280"
  },
  {
    "text": "helping patients and whether that's about you know and what's amazing is that when you ask patients you actually",
    "start": "2963280",
    "end": "2969880"
  },
  {
    "text": "get different questions than when you ask clinicians and so you can't just have one constituent group and expect",
    "start": "2969880",
    "end": "2975700"
  },
  {
    "text": "them to speak for the others because many times patients are acting about asking about the practicality is a",
    "start": "2975700",
    "end": "2980770"
  },
  {
    "text": "different way to treat their disease and aspects of quality of life and side effect profiles that maybe are",
    "start": "2980770",
    "end": "2986560"
  },
  {
    "text": "subclinical but they actually have a profound impact on how the patient experience the treatment of their disease and so I think that I'm you know",
    "start": "2986560",
    "end": "2993880"
  },
  {
    "text": "that's also a place which is really exciting in this area is both capturing and defining those key questions for the",
    "start": "2993880",
    "end": "3000150"
  },
  {
    "text": "future of innovation in the disease it's great Gabriel I want to move on to the",
    "start": "3000150",
    "end": "3005340"
  },
  {
    "text": "second question which is really about what's coming up next that I think we've",
    "start": "3005340",
    "end": "3010410"
  },
  {
    "text": "heard a little bit about this in both of your presentations but in particular what's coming up next and how do we want",
    "start": "3010410",
    "end": "3017640"
  },
  {
    "text": "to view this pillar around data analytics and its relationship with the other three areas and I know you're",
    "start": "3017640",
    "end": "3024270"
  },
  {
    "text": "advancing their craft so I would say",
    "start": "3024270",
    "end": "3029369"
  },
  {
    "text": "when you watch where we're headed everybody is dealing trying to be out the data space and so that workshop on",
    "start": "3029369",
    "end": "3035280"
  },
  {
    "text": "the data piece will become critically important in first quarter but you are right I mean we have to understand how",
    "start": "3035280",
    "end": "3042420"
  },
  {
    "text": "you use data to also drive venture so you know one of the questions we get up here all the time is is that you know",
    "start": "3042420",
    "end": "3048930"
  },
  {
    "text": "you want to have many shots on goal as you can but you want to make sure that the best shots don't go to and so a lot",
    "start": "3048930",
    "end": "3054240"
  },
  {
    "text": "of the work we're doing on venture is also tied to how do we use data in a better space to pick air in",
    "start": "3054240",
    "end": "3059400"
  },
  {
    "text": "vestment so that's a lot of what we'll be working on at our February meeting and if people have venture models that",
    "start": "3059400",
    "end": "3064980"
  },
  {
    "text": "they didn't hear me discuss that they think or compelling by all means let us know I think the other places that we",
    "start": "3064980",
    "end": "3071730"
  },
  {
    "text": "end up really focusing to and where things are coming up is you know this team has done a beautiful job on",
    "start": "3071730",
    "end": "3077190"
  },
  {
    "text": "platform trial sharing their information of what makes them tick and what can be the challenges behind them so when this",
    "start": "3077190",
    "end": "3083279"
  },
  {
    "text": "publication comes out we'll make sure everybody gets a copy of it it's just it's not you know mind blowing just know",
    "start": "3083279",
    "end": "3089279"
  },
  {
    "text": "that there's four major challenges they all face but I think it's just good practice to read this and then hear",
    "start": "3089279",
    "end": "3095520"
  },
  {
    "text": "directly from you know the people that were working with Victoria and Daniel and others to say this is where I got",
    "start": "3095520",
    "end": "3101549"
  },
  {
    "text": "stuck and you know we don't want you to pay the double tax as we call it like when you do your platform trial we want",
    "start": "3101549",
    "end": "3106890"
  },
  {
    "text": "you to get these four things right and and I think that will be you know really helpful so a lot of our ideas",
    "start": "3106890",
    "end": "3114200"
  },
  {
    "text": "that we work on it craft we work on them as these work streams that you just",
    "start": "3114200",
    "end": "3119250"
  },
  {
    "text": "heard about with the work stream leader we're on calls you know for some of these work groups every week we've been doing it like Lloyd Marcus with a",
    "start": "3119250",
    "end": "3125789"
  },
  {
    "text": "director patient group for you know for over a year now and it shows but what",
    "start": "3125789",
    "end": "3131579"
  },
  {
    "text": "you want to be aware of it if you're in our database and working with rhetoric yours now you'll know when all of our workshops are happening that are open",
    "start": "3131579",
    "end": "3138059"
  },
  {
    "text": "meetings you also know exactly when we're communicating and disseminating our solutions through publications will",
    "start": "3138059",
    "end": "3144569"
  },
  {
    "text": "make you aware of all of our case studies anything we're doing in the executive education programs because the",
    "start": "3144569",
    "end": "3149940"
  },
  {
    "text": "whole point of this is to make sure we know where best practices are happening where the white space is that we all",
    "start": "3149940",
    "end": "3156569"
  },
  {
    "text": "need to be working together and while we can't have 400 people in a room but we'll never get anything done we want to",
    "start": "3156569",
    "end": "3162359"
  },
  {
    "text": "make sure we're disseminating it as fast as we possibly can I think my greatest frustration of you know working at the",
    "start": "3162359",
    "end": "3168510"
  },
  {
    "text": "MMRF was we knew a lot and so many other groups or even smarter than we were but",
    "start": "3168510",
    "end": "3174180"
  },
  {
    "text": "there was never an easy way for all of us to get together and share that knowledge and I think that's really what",
    "start": "3174180",
    "end": "3179700"
  },
  {
    "text": "Robert and Jonathan's craft intent was let's share as much information as we can real time across cancers across the",
    "start": "3179700",
    "end": "3187230"
  },
  {
    "text": "ceases and have a much better impact that's great you know I know we're",
    "start": "3187230",
    "end": "3192630"
  },
  {
    "text": "focused precision medicine here today and oftentimes we think about it only restricted to cancer but to your point",
    "start": "3192630",
    "end": "3198940"
  },
  {
    "text": "precision medicine is the direction that all diseases are heading in in the future I wanted to take a step back",
    "start": "3198940",
    "end": "3206470"
  },
  {
    "text": "because Cathy I think you as somebody who's been such a pioneer in the face of",
    "start": "3206470",
    "end": "3211540"
  },
  {
    "text": "venture philanthropy and in the role that patient organizations can play to catalyze an entire environment one of my",
    "start": "3211540",
    "end": "3218850"
  },
  {
    "text": "aha moment to listening to you Gabriel is that the AI and data market is",
    "start": "3218850",
    "end": "3224170"
  },
  {
    "text": "extraordinarily hot it receives a lot of private sector investment and when you",
    "start": "3224170",
    "end": "3229660"
  },
  {
    "text": "think about the role of Disease Foundation they played a critical role in creating rich data sets that are",
    "start": "3229660",
    "end": "3236680"
  },
  {
    "text": "complement to the maps of clinical data sets that we see in academic medical centers how do you see both the role the",
    "start": "3236680",
    "end": "3243880"
  },
  {
    "text": "patient organizations in its contribution to data but also is contribution from a philanthropic",
    "start": "3243880",
    "end": "3249640"
  },
  {
    "text": "venture philanthropy perspective well I think there's two ways one I think the",
    "start": "3249640",
    "end": "3255670"
  },
  {
    "text": "patient groups can really serve as trusted third parties so they can help to prioritize the questions that really",
    "start": "3255670",
    "end": "3262150"
  },
  {
    "text": "need to be answered and then they can find sometimes the use case may be only interesting to one part of the ecosystem",
    "start": "3262150",
    "end": "3268870"
  },
  {
    "text": "other times the use case may be interesting to the entire ecosystem what I really seen this happen is with MRD",
    "start": "3268870",
    "end": "3276030"
  },
  {
    "text": "where everybody benefited because in myeloma the patients didn't necessarily want to be on maintenance therapy if",
    "start": "3276030",
    "end": "3282760"
  },
  {
    "text": "they were in a complete remission and in academia and in industry they were",
    "start": "3282760",
    "end": "3288910"
  },
  {
    "text": "looking for a surrogate endpoint so all of a sudden you see you know a number of data sets coming together and that's",
    "start": "3288910",
    "end": "3295900"
  },
  {
    "text": "where you can be a trusted third party and keep identifying that sweet spot of where data can align and you know really",
    "start": "3295900",
    "end": "3302770"
  },
  {
    "text": "take a leadership role as a third party to move that forward on behalf of everybody I think then how you tie that",
    "start": "3302770",
    "end": "3309520"
  },
  {
    "text": "back into venture is to start making sure that we look at some of these models that are out there and that",
    "start": "3309520",
    "end": "3315160"
  },
  {
    "text": "you're fueling what's going on at GTR JDRF or you know when we teach MMR for",
    "start": "3315160",
    "end": "3320260"
  },
  {
    "text": "LLS and all these groups how to do the venture piece make sure you're also tying it to what is the priorities you",
    "start": "3320260",
    "end": "3326140"
  },
  {
    "text": "see example we keep using it in immunotherapy not every cancer is going to be the same some of us may really",
    "start": "3326140",
    "end": "3332980"
  },
  {
    "text": "care about parties other may care about bite others care about checkpoints without the data you don't know where to make",
    "start": "3332980",
    "end": "3339310"
  },
  {
    "text": "the investment so we're really trying to push the data and tie it to the venture piece as well one thing I want to add",
    "start": "3339310",
    "end": "3346660"
  },
  {
    "text": "you know yeah one day I want to add was that I feel like the role of the",
    "start": "3346660",
    "end": "3353109"
  },
  {
    "text": "nonprofit's also can serve as a platform to disseminate this key questions and also serve as matchmaker between the",
    "start": "3353109",
    "end": "3360310"
  },
  {
    "text": "data owners oftentimes AMC's or other registries with the analytics companies and I think that helping those",
    "start": "3360310",
    "end": "3366849"
  },
  {
    "text": "organizations both find each other and focus in on this key question that the nonprofit wants answer is a really",
    "start": "3366849",
    "end": "3373780"
  },
  {
    "text": "valuable these organizations have tremendous capabilities when it comes to analytics but oftentimes don't quite",
    "start": "3373780",
    "end": "3378970"
  },
  {
    "text": "know the science or the biology the clinical aspects as well and the help would be on nonprofit can really help",
    "start": "3378970",
    "end": "3384940"
  },
  {
    "text": "drive a focus towards those key questions and Noblet funding and partners to do it with I want to thank",
    "start": "3384940",
    "end": "3392589"
  },
  {
    "text": "Kathy and Gabriel further for their wisdom today for sharing all the learnings for those of you that have",
    "start": "3392589",
    "end": "3399099"
  },
  {
    "text": "joined us and those of you that I know have colleagues that wanted to tune in this webinar is being recorded we invite",
    "start": "3399099",
    "end": "3405579"
  },
  {
    "text": "you to access the archived version of this website on our website it'll be posted in the next 24 hours and I know",
    "start": "3405579",
    "end": "3412510"
  },
  {
    "text": "Kathy and Gabriel have a rich amount of resources on their website as well that they have made available to the public",
    "start": "3412510",
    "end": "3418990"
  },
  {
    "text": "for us here at fashion cures one of our core missions as many of you all know is",
    "start": "3418990",
    "end": "3424210"
  },
  {
    "text": "that for over the last 15 years building this community of leaders who are really",
    "start": "3424210",
    "end": "3430359"
  },
  {
    "text": "pushing the envelope like crafted maitake Gabriel is as part of our core mission I really thank you all for being",
    "start": "3430359",
    "end": "3437349"
  },
  {
    "text": "with us today like I said earlier this idea of health data and where we're going as a society",
    "start": "3437349",
    "end": "3444579"
  },
  {
    "text": "around health data and increasing the participation of all of us and research is really critical please visit our",
    "start": "3444579",
    "end": "3451240"
  },
  {
    "text": "website at health data basics org master protocols are incredibly important",
    "start": "3451240",
    "end": "3457270"
  },
  {
    "text": "aspect of what many people are thinking about include our friends at Kraft we have a webinar",
    "start": "3457270",
    "end": "3462959"
  },
  {
    "text": "coming up in December around name so you want to start a master protocol trial",
    "start": "3462959",
    "end": "3469559"
  },
  {
    "text": "the registration for this webinar will be open it's open on our website now and",
    "start": "3469559",
    "end": "3475279"
  },
  {
    "text": "then finally if you'd like to stay connected to faster cures and stay in the know about our latest developments",
    "start": "3475279",
    "end": "3481559"
  },
  {
    "text": "please subscribe to our smart brief or follow us online on Twitter Facebook",
    "start": "3481559",
    "end": "3487579"
  },
  {
    "text": "Linkedin tumblr or on our website thank you all so much for participating in the",
    "start": "3487579",
    "end": "3492779"
  },
  {
    "text": "webinar Thank You Kathy and Gabriel we look forward to our continued partnership with Kraft and see you next",
    "start": "3492779",
    "end": "3499439"
  },
  {
    "text": "time",
    "start": "3499439",
    "end": "3501799"
  }
]